» Articles » PMID: 34025074

Radiofrequency Ablation Surgical Resection in Elderly Patients with Hepatocellular Carcinoma in Milan Criteria

Abstract

Background: Surgical resection and radiofrequency ablation (RFA) represent two possible strategy in treatment of hepatocellular carcinoma (HCC) in Milan criteria.

Aim: To evaluate short- and long-term outcome in elderly patients (> 70 years) with HCC in Milan criteria, which underwent liver resection (LR) or RFA.

Methods: The study included 594 patients with HCC in Milan criteria (429 in LR group and 165 in RFA group) managed in 10 European centers. Statistical analysis was performed using the Kaplan-Meier method before and after propensity score matching (PSM) and Cox regression.

Results: After PSM, we compared 136 patients in the LR group with 136 patients in the RFA group. Overall survival at 1, 3, and 5 years was 91%, 80%, and 76% in the LR group and 97%, 67%, and 41% in the RFA group respectively ( = 0.001). Disease-free survival at 1, 3, and 5 years was 84%, 60% and 44% for the LR group, and 63%, 36%, and 25% for the RFA group ( = 0.001).Postoperative Clavien-Dindo III-IV complications were lower in the RFA group (1% 11%, = 0.001) in association with a shorter length of stay (2 d 7 d, = 0.001).In multivariate analysis, Model for End-stage Liver Disease (MELD) score (> 10) [odds ratio (OR) = 1.89], increased value of international normalized ratio (> 1.3) (OR = 1.60), treatment with radiofrequency (OR = 1.46) ,and multiple nodules (OR = 1.19) were independent predictors of a poor overall survival while a high MELD score (> 10) (OR = 1.51) and radiofrequency (OR = 1.37) were independent factors associated with a higher recurrence rate.

Conclusion: Despite a longer length of stay and a higher rate of severe postoperative complications, surgery provided better results in long-term oncological outcomes as compared to ablation in elderly patients (> 70 years) with HCC in Milan criteria.

Citing Articles

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects.

Wang H, Wu Z, Cui D, Shi Y, Zhai B Liver Res. 2025; 7(2):108-115.

PMID: 39958948 PMC: 11791925. DOI: 10.1016/j.livres.2023.05.002.


Refining MR-guided thermal ablation for HCC within the Milan criteria: a decade of clinical outcomes and predictive modeling at a single institution.

Wei F, Huang P, Zhang B, Guo R, Yuan Y, Chen J BMC Cancer. 2025; 25(1):159.

PMID: 39875824 PMC: 11773734. DOI: 10.1186/s12885-025-13510-8.


Benefits and drawbacks of radiofrequency ablation percutaneous or minimally invasive surgery for treating hepatocellular carcinoma.

Hsieh C, Peng C, Chen C, Liu C, Teng C, Liu Y World J Gastrointest Surg. 2024; 16(11):3400-3407.

PMID: 39649197 PMC: 11622093. DOI: 10.4240/wjgs.v16.i11.3400.


Open, laparoscopic liver resection and percutaneous thermal ablation in elderly patients with hepatocellular carcinoma: outcomes and therapeutic strategy.

Delvecchio A, Conticchio M, Casella A, Ratti F, Gelli M, Anelli F Surg Endosc. 2024; 38(11):6700-6710.

PMID: 39317909 DOI: 10.1007/s00464-024-11269-w.


Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.

Kim J, Lee J, Choi G, Lee M, Park D, Yoo J Dig Dis Sci. 2024; 69(3):1055-1067.

PMID: 38300416 DOI: 10.1007/s10620-023-08245-0.


References
1.
Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y . Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg. 2009; 16(3):359-66. DOI: 10.1007/s00534-009-0069-7. View

2.
Feng K, Yan J, Li X, Xia F, Ma K, Wang S . A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012; 57(4):794-802. DOI: 10.1016/j.jhep.2012.05.007. View

3.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

4.
Xu X, Liu X, Liang M, Luo B . Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis. Radiology. 2017; 287(2):461-472. DOI: 10.1148/radiol.2017162756. View

5.
Lau W, Leung T, Yu S, Ho S . Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003; 237(2):171-9. PMC: 1522146. DOI: 10.1097/01.SLA.0000048443.71734.BF. View